Skip to main content
MedicineWatch US
Explore records
Trends
Coverage
About
Methodology
Report an issue
Privacy
LEO PHARMA INC
Provisional
Madison, NJ · united states
1 recall flag(s)
FDA Flags (1)
Class II Recall
Mar 2026
LEO PHARMA INC
Adbry, (tralokinumab-ldrm) injection, 300 mg/2mL, Packaged as a) 1 x Single dose Autoinjector, SAMPLE NOT FOR SALE, NDC
Classification: Class II